Metropolitan Life Insurance CO Solid Biosciences Inc. Transaction History

Metropolitan Life Insurance CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$7.19 - $32.37 $29,910 - $134,659	-4,160 Closed	0 $0
Q4 2018 Jul 13, 2023	BUY	$21.32 - $46.34 $88,691 - $192,774	4,160 New	4,160 $111,000
Q4 2018 Feb 14, 2019	BUY	$21.32 - $46.34 $69,268 - $150,558	3,249 Added 356.64%	4,160 $111,000
Q3 2018 Jul 13, 2023	BUY	$36.35 - $51.7 $151,216 - $215,072	4,160 New	4,160 $196 Million
Q3 2018 Nov 14, 2018	BUY	$36.35 - $51.7 $33,114 - $47,098	911 New	911 $43,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $53.2M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.